A 1891 New Jersey General Assembly · 2024-2025 Regular Session

Requires SHBP, SEHBP, Medicaid, and NJ FamilyCare to cover anti-obesity medications.

This bill requires New Jersey's State Health Benefits Program (SHBP), School Employees Health Benefits Program (SEHBP), Medicaid, and NJ FamilyCare to cover FDA-approved anti-obesity medications for enrolled members who meet specific criteria. It mandates coverage if a member has a diagnosed obesity-related condition (like diabetes or high blood pressure), is prescribed the medication by a qualified provider (doctor, nurse practitioner, or physician assistant), and receives it from an approved pharmacy. The coverage applies to all members of these state health programs, including state employees, school staff, and low-income residents enrolled in Medicaid or NJ FamilyCare. Implementation depends on securing federal approval for Medicaid coverage changes, as noted in the bill.
Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2024
Committee Review
Floor Vote
Governor
Introduced Jan 9, 2024 Last action Jan 9, 2024
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
1
Key actions
0
Committee
0
Jan 9, 2024
Introduced
Introduced in the Assembly, Referred to Assembly Health Committee
lower
1 primary · 2 co-sponsors

Sponsors